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Hyperlipidemia and hyperglycemia have been implicated in diabetes      mellitus (DM) 
leading to complications such as nephropathy. Medicinal plants like Mormodica charantia 
(MC) have been used in the treatment of DM over the years but little is known about their 
mechanisms of action. This study used biotechnology tools to investigate and compare the 
effects of M. charantia silver nanoparticles (MCSNPs) with M. charantia extract on 
expressions of genes linked with nephrotoxicity, lipid and glucose metabolisms using 
reverse-transcriptase polymerase chain reaction (RT-PCR) in streptozotocin-induced 
diabetic rats. The genes investigated include kidney injury molecule-1 (KIM-1), 3-
hydroxyl, 3-methyl glutaryl_coA reductase (HMG-CoA reductase), peroxisome proliferator-
activated receptor alpha and gamma (PPARα and PPARγ). Synthesis of MCSNPs was done 
using 1 mM concentration of aqueous silver nitrate solution at ratio 1:9 (v/v). Experimental 
rats were induced intraperitoneally with streptozotocin (65 mg/kg) and divided into six 
groups viz: diabetic control; normal control; silver nitrate (10 mg/kg); MCSNPs (50 
mg/kg); Metformin (100 mg/kg) and M. charantia fraction (100 mg/kg). Sacrifice was 
done after 12 days of treatment and RT-PCR was then used to investigate gene expressions 
in liver and kidney tissues of the rats. The expression of HMG-CoA reductase gene was 
significantly upregulated (p<0.05) upon treatment with 50 mg/kg MCSNPs relative to the 
diabetic untreated group. M. charantia extracts and MCSNPs significantly upregulate      
(p<0.05) the expressions of PPAR-α and PPAR-γ      compared to the      diabetic control. 
Also, a significant (p<0.05) down-regulation of KIM-1 mRNA expression was observed in 
MCSNPs-     treated group, relative to the diabetes untreated group. M. charantia silver 
nanoparticles could be a potent antidiabetic agent due to its potential to modulate genes 
associated with lipid metabolism and nephrotoxicity. 
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Diabetes mellitus (DM) describes a group of 
metabolic disorders which is characterized by 
high blood glucose (blood sugar), either due to 
inadequate insulin secretion or action or both 
(WHO 2006, Elekofehinti et al., 2016; 2018). As 
of 2015, an estimated 415 million people were 
diagnosed with diabetes mellitus worldwide, 
this is projected to rise to 430 million in 2030 
with type 2 DM making up about 90% of the 
cases (Shaw et al., 2010).  In DM cases, there 
is impediment in glucose process in its 
catabolism as immediate energy source or 
anabolism as glycogen for storage, as a result 
of insulin deficiency, inadequacy or 
malfunctioning. Complications of DM can be 
short-     term or long-     term; they include 
nephropathy, urinary infections, retinopathy, 
neuropathy, cardiovascular diseases, 
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ketoacidosis and weight loss (Bloomgarden, 
2003; Kitabchi et al., 2009;). DM may result in 
kidney stone formation, partial or total kidney 
failure. This disorder is the major cause of 
kidney failure in the developed world and 
accounts for approximately 35 to 40 % of cases 
of End Stage Renal Disease (ESRD) each year 
(Mbanya and Sobngwi, 2003). 
Conventional antidiabetic drugs like metformin, 
acarbose, sulphonylureas and biguanides 
among others have been found to have side 
effects, unlike the use of      medicinal plants 
which have been reported to have little or no 
side effects (Omonkhua et al., 2012; 
Elekofehinti et al., 2014; Ahn, 2017). 
Phytomedicine or Plant-based medicine has 
been used cost-effectively to treat diabetes 
mellitus worldwide. In many parts of the planet, 
especially poor countries, this may be the only 
form of therapy available to treat diabetic 
patients. There are several documented 
evidences about anti-diabetic herbal plants like 
Mormodica charantia (Patel et al., 2010). 
Hypoglycemic herbs increase insulin secretion, 
enhance glucose uptake by adipose or muscle 
tissues and inhibit glucose absorption from 
intestine and glucose production from liver (Hui 
et al., 2009).  
Nanoparticles can be used as carriers of drugs 
in order to overcome the enzymatic 
degradation in the stomach and improve 
permeation through the gastrointestinal (GI) 
tract. They can be synthesized by solid reaction, 
co-precipitation, chemical reaction, sol gel 
method, microwave irradiation and green 
synthesis among others (Shameli et al., 2010). 
The various nanoparticles include gold, silver, 
copper, iron, palladium; and among these, 
silver nanoparticles are known to be excellent 
(Zhang et al., 2016).  
One of the major concerns in drug delivery is 
bioavailability at the target sites and 
conventional drugs/herbs administered through 
oral route may not get to the target tissues at 
the required dose. This study was designed to 
synthesize silver nanoparticles using a lower 
dose of M. charantia, and compare      its effects 
with a higher dose of M. charantia aqueous 
extract on selected genes associated with 
nephrotoxicity, lipid and glucose metabolism in 
streptozotocin-induced diabetic rats. The genes 
investigated in the study include kidney injury 
molecule-1 (KIM-1), 3-hydroxyl, 3-methyl 
glutaryl coA reductase (HMG-CoA reductase), 
peroxisome proliferator-activated receptor 
alpha and gamma (PPARα and PPARγ).  
 
Materials and Methods 
Materials 
Chemicals, reagents and solvents used during 
this research were of analytical status.  Silver 
nitrate      and methanol were products of Sigma 
Chemical Co. (USA). Trizol, reverse 
transcriptase, gel loading dye, TBE buffer      
and DNA ladder were purchased from Inqaba 
Biotec South Africa 
 
Methods 
Bitter melon leaves (Momordica charantia) 
were collected from within Akure, Ondo State, 
Nigeria. They were air-     dried and grou     nd     
. The bitter lemon nanoparticles      were      
synthesized according to the modified method 
of Bharathi et al. (2017). Briefly, filtrate from 
the plant extract was added to 1mM 
concentration of aqueous silver nitrate solution 
at the ratio 1: 9 (v/v). The resulting solution 
was then left for about 24hrs for the 
nanoparticles to be fully formed. Change in 
colour of the solution from dark green      to 
light brown was observed, which became 
deeper after 24 hrs,      indicating the formation 
of silver nanoparticles. The bio reduction of Ag+ 
ions to Ag0 was monitored using a UV-Vis 
spectrophotometer to take the absorbance, 
since nanoparticles formation is evidenced by 
the appearance of surface plasmon resonance 
band at 420-470nm. The nanoparticles solution 
was then freeze-     dried and stored at room 
temperature to enhance stability (Abdelwahed 
et al., 2006). The nanoparticles were further 
characterized using a Scanning      Electron      
Microscope (SEM) and Fourier Transformed 
Infrared Spectroscopy      (FTIR) (Bharathi et 
al., 2017). 
Experimental design and Animal Treatment 
Male Wistar rats were used for this study. The 
animals were housed at the animal house of the 
Biochemistry Department, Federal University of 
Technology, Akure, Ondo State, Nigeria. The 
animals were then acclimatized and randomly 
allocated into 6 groups containing at least 6 
animals per group.  Diabetes mellitus was 
induced by intraperitoneal (i.p) injection freshly 
prepared and buffered (0.1 M citrate, pH 4.5) 
solution of streptozotocin (STZ) at      65 
mg/kg/body weight       into the overnight 
fasted rats. After 72 hrs, the animals with blood 
glucose ≥200 mg/dl were selected and used for 
subsequent experiments (Akbarzadeh et al., 
2007; Elekofehinti et al., 2020). The six groups 
are as follows: control, diabetes-induced, and 
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treatment groups (with silver nitrate (10 
mg/kg), M. charantia silver nanoparticles (50 
mg/kg), Metformin (100 mg/kg), and M. 
charantia aqueous extract (100 mg/kg)). The 
treatment lasted for 12 days after which the 
animals were sacrificed by cervical dislocation 
(Elekofehinti et al., 2020).      Livers and kidneys 
of the animals were excised, blotted and put in      
Eppendorf tubes containing trizol solution.  
 
Gene expression  
Total ribonucleic acid (RNA) was isolated after 
homogenizing      the      rats’ livers and kidneys 
with TRIzol Reagent (Thermo Fisher Scientific).      
DNA contaminant was removed following 
DNAse treatment. The RNA was then quantified 
and the purity checked using 
spectrophotometer (A and E Lab UK) at 260 and 
280 nm. The RNA was later converted to cDNA 
using ProtoScript First Strand cDNA Synthesis 
Kit (NEB). PCR amplicons were gotten using 
OneTaq
® 
2X Master Mix (NEB) using the 
following primer set (Table 1)
 
Table 1: Primer sets for the gene expression 























































Polymerase Chain Reaction (PCR) 
This has been previously described 
(Elekofehinti et al., 2020). 5 μl of the cDNA 
template was used to amplify each gene using      
2 μl of each of the forward and reverse primers 
with Taq-master mix in a final volume of 15 μl. 
The PCR      was      run           as follows: pre-
denaturation for 5 min at 94 °C, annealing for 
30 sec at 55 °C and Extension 72 °C for 30 sec. 
This was followed by 30 cycles run for 5 min at 
72 °C.  
 
Gel electrophoresis 
The PCR      products (amplicons) were 
electrophoresed in 0.2%      agarose gel using 
0.5 × TBE buffer with 3μl EZ-vision (VWR Life 
Science).                The bands were      visualized      
using Blue-light-transilluminator (Blue box 
U.S.A). The intensities of the bands from 
agarose gel electrophoresis were quantified 
densitometrically using Image J software. The      
results obtained      were plotted as bar graphs.  
 
Statistical analysis 
The experimental results were expressed as 
mean ± standard error of the mean (SEM) 
using Graph Pad Prism 8.0.2 and were 
subjected to one-way analysis of variance 
followed by post-hoc Dunnett's multiple range 




Effect of M. charantia silver nanoparticles on glucose level in streptozotocin- induced diabetic 
Rats 
 




































STZ + SN (10 mg/kg)
STZ + MCSNPs (50 mg/kg)
STZ + Met (100 mg/kg)
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Fig 1: Graph showing the hypoglycemic effect of M. charantia nanoparticles on glucose level in 
streptozotocin-induced diabetic rats. Experiments were conducted in triplicates and all data are 
presented as Mean ± SD (n = 6-8 animals) 
 
Effect of oral administration of M. charantia silver nanoparticles on 3-hydroxyl, 3-methyl glutaryl_coA 




Fig 2: Qualitative-PCR analysis of 3-hydroxyl, 3-methyl glutaryl_coA reductase (HMG-CoA reductase) 
mRNA expression in STZ-induced diabetic rats. Snapshot representation of RT-PCR agarose gel 
electrophoresis for HMG-CoA reductase followed by densitometric analysis. *represents significant 
difference relative to control, # represents a significant difference relative to diabetic control at p<0.05. 
 
Effect of oral administration of M. charantia silver nanoparticles on peroxisome proliferator-activated 

















Fig. 3: Qualitative-PCR analysis of peroxisome proliferator-activated receptor alpha (PPARα) gene 
expression in STZ-induced diabetic rats. Snapshot representation of RT-PCR agarose gel electrophoresis 
for PPARα followed by densitometric analysis. *represents significant difference relative to control, # 
represents a significant difference relative to diabetic control at p<0.05. 
 
Effect of oral administration of M. charantia silver nanoparticles on peroxisome proliferator-activated 


















Fig. 4: Qualitative-PCR analysis of peroxisome proliferator-activated receptor alpha and gamma 
(PPARγ) gene expression in STZ-induced diabetic rats. Snapshot representation of RT-PCR agarose gel 
electrophoresis for PPARγ followed by densitometric analysis. *represents significant difference relative 
to control, # represents significant difference relative to diabetic control at p<0.05 
 
The effect of oral administration of M. charantia silver nanoparticles at different concentrations on 
kidney injury molecule-1 (Kim-1) gene expression in the kidney of normal and STZ-induced diabetic 
rats 
 
Fig. 5: Qualitative-PCR analysis of Kim-1 gene expression in STZ-induced diabetic rats. Snapshot 
representation of RT-PCR agarose gel electrophoresis for Kim-1 followed by densitometric analysis. 
*represents significant difference relative to control, # represents significant difference relative to 
diabetic control at p<0.05 
Discussion 
Diabetes Mellitus (DM) is characterized by 
hyperglycemia and has also been linked with 
hypercholesterolemia (a form of 
hyperlipidemia) which is often the genesis of 
many cardiovascular diseases such as 
hypertension, myocardial infarction, stroke and 
the likes seen in DM complications (Dowarah 
and Singh, 2020). Another complication is 
nephropathy; partial or total kidney malfunction 
which has been reported in DM cases (Mbanya 
and Sobngwi, 2003). Streptozotocin was used 
to induce DM in this study since it has been 
known to cause apoptosis of insulin-producing 
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beta-cells of the pancreas resulting in      
hyperglycemia (Elekofehinti et al., 2020). 
The hypolipidemic and antidiabetic effect of 
Mormodica charantia has been reported (Oishi 
et al., 2007; Elekofehinti et al., 2018). 
However, there is dearth of information on its 
mechanisms and its use with silver 
nanoparticles as vehicles for treatment. This 
study investigated the effect of M. charantia 
silver nanoparticles (MCSNPs) on genes 
associated with lipid metabolism and 
nephrotoxicity in streptozotocin-induced (STZ-
induced) diabetic rats. Genes like 3-hydroxyl, 3-
methyl glutaryl_coA reductase (HMG-CoA 
reductase), peroxisome proliferator-activated 
receptor alpha and gamma (PPARα and PPARγ) 
were investigated in the liver of MCSNPs 
treated rats since liver is central in lipid 
metabolism (Staels and Fruchart 2005). Liver 
stores excess fatty acids as triacyl glycerides 
(TAG) and it is also responsible for production 
of bile acids. Kidney injury molecule 1 (KIM-1), 
a sensitive marker gene associated with 
nephrotoxicity was also examined in the kidney.  
The blood glucose of the rats was significantly 
(p<0.05) elevated after 72 hours (3 days) of 
induction with streptozotocin (65 mg/kg) as 
seen in Fig 1 above. This is because 
streptozotocin (STZ) has the ability to destroy 
the insulin producing cells in the pancreas 
resulting in elevated blood sugar since insulin 
together with the liver regulates glucose and 
fatty acid metabolism (Al-Qattan et al., 2008). 
M. charantia nanoparticles (MCSNPs) and M. 
charantia plant extract (MC.E) significantly 
(p<0.05) lowered blood glucose of diabetic rats 
after 12 days of treatment. This could imply 
that the plant resuscitated beta cells of the 
pancreas enabling more insulin to be produced 
thus ensuring glucose homeostasis. Stimulation 
of insulin secretion of M. charantia has also 
been reported (Keller et al., 2011). 
3-hydroxyl, 3-methyl glutaryl coA reductase 
(HMG-CoA reductase) is a rate-controlling 
enzyme of the mevalonate pathway that 
produces cholesterol (Cherng et al., 2008). The 
expression of liver HMG-CoA reductase was 
significantly (p<0.05) down-regulated in STZ-
induced group relative to control as seen in Fig 
2. This could result to hypercholesterolemia and 
hyperglycaemia seen since cholesterol 
synthesis pathway is not regulated. Continuous 
synthesis of cholesterol in the long term may 
result in its accumulation on receptors leading 
to insulin resistance. Decrease in the activity of 
HMG-CoA reductase has also been reported in 
diabetes cases (Xiujuan et al., 2015). M. 
charantia silver nanoparticles significantly 
(p<0.05) upregulate the expression of HMG-
CoA reductase relative to diabetic group. This 
could help in regulation of cholesterol synthesis 
via the feedback mechanism caused by 
accumulation of mevalonate in the cholesterol 
biosynthesis pathway. Inhibition of sterol 
production by accumulation of mevalonate as 
also been reported (DeBose-Boyd, 2008). 
Peroxisome proliferator-activated receptors 
(PPARs) is a superfamily of transcription factors 
which include isoforms such as PPAR-alpha and 
PPAR-gamma (Florian et al., 2006). PPAR-alpha 
modifies      insulin resistance and ensures 
glucose homeostasis in the liver while PPAR-
gamma regulates the genes involved in lipid 
metabolism (Florian et al., 2006).      PPAR-
alpha and PPAR-gamma were significantly 
(p<0.05) down-regulated in the STZ-induced 
group relative to the control as seen in Fig 3 
and 4. This could be the reason for the 
hyperglycemia and hypercholesterolemia seen 
in the STZ-induced group since these genes 
ensure glucose and fatty acid homeostasis. M. 
charantia nanoparticles (MCSNPs) and M. 
charantia aqueous extract (MC.E) significantly 
(p<0.05) up-regulated the expression of PPAR-
alpha and PPAR-gamma compared to STZ 
group. This may be due to these genes 
ensuring fatty acid storage and enhancing 
insulin secretion and function as supported by 
the work of Chigurupati et al. (2015). There is 
no significant difference between both MCSNPs 
(50 mg/kg) and M. charantia extracts (100 
mg/kg) for      both genes, indicating that silver 
nanoparticle could ensure bioavailability at a 
lower dosage of M. charantia. 
Kidney injury molecule-1 (KIM-1) proteins are 
secreted by the kidney into the urine and have 
been found to be sensitive markers of acute 
kidney injury (Van Timmeren et al., 2007). 
Kidney injury molecule-1 (KIM-1) gene 
expression (Fig. 5) was up-regulated in STZ-
induced test rats when compared to control 
rats. This showed that hyperglycemia could be 
capable of inducing nephrotoxicity. KIM-1 gene 
expression was downregulated in MCSNPs and 
M. charantia extracts relative to the diabetic 
control rats. This could mean the plant has 
ameliorative effect on diabetes     -induced 
kidney malfunction     . 
Conclusion 
This study revealed that M. charantia silver 
nanoparticles (MCSNPs) and M. charantia 
extracts administered to streptozotocin-induced 
diabetic rats improves or ameliorates diabetes      
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conditions by up-regulating the expression of 
HMG-CoA reductase, PPAR-alpha and PPAR-
gamma coupled with down-regulating KIM-1, a 
gene associated with nephrotoxicity. However, 
there is no significant difference in the 
modulation of genes in both MCSNPs 50 mg/kg 
and M. charantia extracts 100 mg/kg groups. 
This work revealed that silver nanoparticle 
technology ensures bioavailability of M. 
charantia at less dosage (50 mg/kg). The study 
further indicated that coupling drugs      with 
silver nanoparticles as seen in administration of 
M. charantia silver nanoparticles could be an 
improved, dosage-effective and viable 
alternative in the management of diabetes 
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